Next, we used the same strategy as described above for GBM180 to perform HTDS (using Cmax and 10% Cmax for each of the drugs) across all 10 EGFR-driven GBM samples included in Table S1 (and also shown in Figure 1b). The gene discussed is EGFR; the disease is glioblastoma.